C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting
September 20, 2025 11:00 ET | Source: C4 Therapeutics, Inc. Cemsidomide in…
Nxera Pharma and Cancer Research UK Announce First Patient Dosed in Phase 2a Trial of Investigational Cancer Immunotherapy HTL0039732
HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist being…
Happiest Health Announces Ethics in Healthcare Summit 2025: A Platform for Trust, Transparency & Reform
BENGALURU, India, Sept. 16, 2025 /PRNewswire/ -- Happiest Health, India's leading wellness…
ALCOR Scientific Transforms ESR Testing: Extends Blood Sample Stability from 4 to 28 Hours
Diagnostic Company's iSED Analyzers Deliver Seven-Fold Stability Increase to Improve Accuracy, Efficiency,…
Akumin Selected to Exhibit Akumin AXIS at Vizient Innovative Technology Exchange
PLANTATION, Fla.--(BUSINESS WIRE)--Akumin Inc. (“Akumin” or the “Company”), a leader in managed…
KFSHRC Deputy CEO at C3 Davos of Healthcare Summit: AI Will Support, Not Replace, Healthcare Workers
NEW YORK, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Artificial intelligence is ready…
Medidata Secures a Leader Position in Everest Group’s PEAK Matrix Assessment for eCOA, Driving the New Patient Experience Forward
Medidata eCOA was the highest Leader recognized in the evaluation, supporting over…
Osstem Implant Strengthens Position in India, Reinforcing the Global Reputation of ‘K-Implant’
SEOUL, South Korea, Aug. 28, 2025 /PRNewswire/ -- India's dental implant sector…
A Life Rewritten: KFSHRC Treats Rare Disease After 22 Years of Specialized Care
RIYADH, Saudi Arabia, Aug. 24, 2025 (GLOBE NEWSWIRE) -- In a rare…
ZEISS announces CE mark for CIRRUS PathFinder AI tool with automated OCT assessment
Fully integrated AI decision support tool flags B scans that may require…